BONNEY MICHAEL W
SEC insider (Form 3/4/5 filer). CIK 0001219016. Director at Autolus Therapeutics plc (AUTL) and 2 other issuers. 21 reported Form 4/5 transactions since Sep 2024; latest on Jun 29, 2026. Located in LONDON.
Companies BONNEY MICHAEL W has filed insider reports for
- Autolus Therapeutics plc (AUTL): Director
- IMMUNIC, INC. (IMUX): Director
- ALNYLAM PHARMACEUTICALS, INC. (ALNY): Director
BONNEY MICHAEL W
CIK: 0001219016
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (21 total)
- Jun 29, 2026AUTL
Autolus Therapeutics plc
AwardDirectRestricted Share Units
31.7K shares- - Jun 29, 2026AUTL
Autolus Therapeutics plc
AwardDirectShare Option (Right to Buy)
47.5K shares- - Jun 29, 2026IMUX
IMMUNIC, INC.
AwardDirectStock Option
100K shares- - Aug 18, 2025ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect11.3K shares at avg. $450.00$5.1M - Aug 18, 2025ALNY
ALNYLAM PHARMACEUTICALS, INC.
ExerciseDirect11.3K shares at avg. $70.20$790K - May 15, 2025ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect245 shares at avg. $269.79$66K - May 15, 2025ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect729 shares at avg. $268.56$196K - May 15, 2025ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect882 shares at avg. $273.75$241K - May 15, 2025ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect549 shares at avg. $267.14$147K - May 15, 2025ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect660 shares at avg. $273.16$180K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 29, 2026 |  AUTL Autolus Therapeutics plc | Award Restricted Share Units | 31,667 | - | - | Direct |
| Jun 29, 2026 | AUTL Autolus Therapeutics plc | Award Share Option (Right to Buy) | 47,500 | - | - | Direct |
| Jun 29, 2026 |  IMUX IMMUNIC, INC. | Award Stock Option | 100,000 | - | - | Direct |
| Aug 18, 2025 |  ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 11,250 | $450.00 | $5,062,500 | Direct |
| Aug 18, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Exercise | 11,250 | $70.20 | $789,750 | Direct |
| May 15, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 245 | $269.79 | $66,099 | Direct |
| May 15, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 729 | $268.56 | $195,780 | Direct |
| May 15, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 882 | $273.75 | $241,448 | Direct |
| May 15, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 549 | $267.14 | $146,660 | Direct |
| May 15, 2025 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 660 | $273.16 | $180,286 | Direct |
1-10 of 21 transactions